Lekha Mikkilineni (@LMikkMD) profile picture

Assistant Professor in the BMT Division at Stanford University School of Medicine . I focus on multiple myeloma and CAR T-cell therapy.

Palo Alto, CA
Joined July 2018
Photo by Lekha Mikkilineni (@LMikkMD)Photo by Lekha Mikkilineni (@LMikkMD)Photo by Lekha Mikkilineni (@LMikkMD)
Lekha Mikkilineni retweeted
The ASH Trainee Council application is now open! Be the voice of hematology trainees, lead new initiatives, and help build programs to support the future of hematology throughout the year. 📅 Apply by March 1, 2027 ow.ly/IIvS5106ztn #ASHTrainee #Hematology #HemeOnc
2
7
1,402
Lekha Mikkilineni retweeted
Out now in @JCO_ASCO! Can we better identify which patients with RRMM will experience early treatment failure vs durable benefit from bispecific T-cell engagers? Across 943 treatment initiations in the US Multiple Myeloma Immunotherapy Consortium cohort, we developed a simple, pragmatic, and reproducible prognostic model: the CHARGE index. We then externally validated CHARGE in an independent, multicenter cohort from the @IMFmyeloma data registry. ascopubs.org/doi/10.1200/JCO… 🧵 1/ Topline findings 👇
10
26
70
4,804
Congratulations to Stanford Cancer Institute members Maximilian Diehn, MD, PhD, and our own David Miklos, MD, PhD on receiving the PMWC - Precision Medicine World Conference 2027 Pioneer and Luminary Award!
3
7
383
Lekha Mikkilineni retweeted
ASH CRTI offers hematology fellows & junior faculty a year-long experience spanning research methods, statistical analysis, collaboration, & career development. Start your application today! LOIs are due by Dec. 17: ow.ly/kM7O5105Buv #ASHTrainee
5
10
1,922
Congratulations to SCI member @max_diehn and David Miklos on receiving the PMWC - 2027 Pioneer and Luminary Awards! #PMWC2027
4
8
420
A major update from ASTCT! New consensus grading criteria refine CRS and ICANS assessments and address emerging toxicities following immune effector cell therapy, supporting standardized toxicity evaluation across clinical trials and practice. ow.ly/Wsig5103RX0
3
52
1
109
6,825
The transition out of pediatric care is when adults with sickle cell disease are most at risk of falling through, #StanDOM's May Chien says. She & Giselle Salmasi are building a care structure to close that gap. stanford.io/4A9RmDD
4
7
413
Lekha Mikkilineni retweeted
In a new NEJM Voices blog post, Don Dizon, MD, reflects on grief and the importance of having our losses acknowledged. Read “Disenfranchised Grief” and sign up for email alerts: nej.md/4imrDSk
3
4
18
8,855
Lekha Mikkilineni retweeted
Have a #QualityImprovement idea for hematologic care? Turn it into measurable impact with QITI. The no-cost, 12-month program provides multidisciplinary teams with QI training, mentorship & dedicated coaching. Apply by Feb. 1: ow.ly/BcFo5102NQM #Hematology
1
9
2,048
Lekha Mikkilineni retweeted
Science Saturday: Could what we eat influence how well cancer immunotherapy works? Researchers have long observed an “obesity paradox” in cancer. A new study explored whether body weight itself is responsible or whether diet and the gut microbiome may offer a better explanation.

4
23
1
243
356,232
"Stress doesn't come about from events. Stress results from the view you take of the event," said @Harvard social psychologist Ellen Langer (@ellenjl) during her talk, "Thinking Our Way to Chronic Health," at last week's Medicine Grand Rounds.
1
4
4
449
Lekha Mikkilineni retweeted
Woke up today to news of flying cars but am still using the fax machine at work The future remains tantalizingly out of reach
16
28
4
362
9,404
"If we could learn to communicate differently, we might be able to care for each other differently," said @waynemedicine & @MSUMD's @RanaAwdish, a critical care physician & author of the memoir "In Shock," during the Brooke Gabster Lecture at #StanDOM Medicine Grand Rounds.
4
7
577
Lekha Mikkilineni retweeted
BCMA×GPRC5D dual-targeted CAR-T therapy BMS-986453 showed >90% response rates at two dose levels in ongoing first-in-human early-phase trial, w/ 100% response 100% MRD-negativity in BCMA/GPRC5d-naïve pts --- Doris Hansen, MD #IMS26
1
16
30
1,365
Lekha Mikkilineni retweeted
Phase I results of Anito-cel and d-domain story published in NEJM! Exciting results and very delighted to be a part of this study @MedicalCollege @MCWCancerC2u8v
In a phase 1 study of anito-cel, a CAR T-cell therapy, for relapsed or refractory myeloma, all 38 patients had a response. Severe cytokine release syndrome and immune effector cell–associated neurotoxicity syndrome were rare. Full study results: nej.md/4ArvK6r Science behind the Study: Anito-cel for Multiple Myeloma nej.md/4hF5Gxj
2
9
45
4,372
Lekha Mikkilineni retweeted
Protein location shapes protein function. A new review highlights how multilocalization enables multifunctionality, while mislocalization contributes to disease. SCI member Emma @Prof_Lundberg & others explore the future of spatial biology. brnw.ch/21x5Uo1
10
1
33
12,218
Lekha Mikkilineni retweeted
Replying to @DrKrinaPatel
@DrKrinaPatel shining at #IMS26 in making a case for CART at first relaps. 1. Outcomes are better when CART is done earlier 2. Better Tumor Microenvironment and T cell Health 3. treatment free time, one and done approach #mmsm
16
3
28
3,097
Lekha Mikkilineni retweeted
If you are in Glasgow #IMS26 stopby 12-1 pm poster- Mezigdomide post ide-cel in RRMM. We demonstrate in likited number that mezigdomide is safe as time limited maintenance for 1 yr at 0.6 mg. imsannual2026.eventscribe.ne…
2
13
1
49
2,683
Lekha Mikkilineni retweeted
Day 1 - 18 km Day started off dry- but we quickly realizing that wasn’t the reality. We did it! Please keep supporting us - we are almost at 90k, 10k shy of our goal! #MedTwitter #hematology #mmsm #oncology #cancer
1
7
1
31
3,030
Now $13.5K shy of their target - so proud of this all-star #WoMMen team!! Not too late to donate before the #IMS26 meeting in Glasgow - link 👇🏼, funds for myeloma research. I spy #tanyawildes bracelets and will have to find the #downwithdex one she'd made for me... so cool!
The WoMMen of Myeloma are ready to hike the Scottish Highlands. give.healthtree.org/campaign… We are 14K shy of our target! So support us! #MedTwitter #oncology #mmsm #hematolgy #research
6
27
2,588